Growth of bacteriophage f2 in E. coli treated with rifampicin.
D001426:Bacterial Proteins / Q000032:analysis / Q000096:biosynthesis; D002247:Carbon Isotopes; D002499:Centrifugation, Density Gradient; D003090:Coliphages / Q000254:growth & development*; D004586:Electrophoresis; D004926:Escherichia coli / Q000187:drug effects*; D007700:Kinetics; D008025:Ligases / Q000037:antagonists & inhibitors; D008239:Lysine / Q000378:metabolism; D012316:RNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D012329:RNA, Bacterial / Q000032:analysis; D012367:RNA, Viral / Q000096:biosynthesis; D012260:Ribonucleases / Q000378:metabolism; D012293:Rifampin / Q000494:pharmacology*; D014316:Tritium; D014498:Uracil / Q000378:metabolism; D014764:Viral Proteins / Q000096:biosynthesis
D001426:Bacterial Proteins; D002247:Carbon Isotopes; D012329:RNA, Bacterial; D012367:RNA, Viral; D014764:Viral Proteins; D014316:Tritium; D014498:Uracil; D012316:RNA Nucleotidyltransferases; D012260:Ribonucleases; D008025:Ligases; D008239:Lysine; D012293:Rifampin